Current status and outcomes in heart transplantation: a narrative review

Area of Science:

• Cardiology
• Immunology
• Transplantation Medicine

Background:

• The first human heart transplant occurred in 1967, with allograft rejection being a primary challenge.
• Cyclosporine discovery ushered in the modern era of heart transplantation, improving survival rates.
• Heart transplantation is the optimal treatment for end-stage heart failure, offering a median survival exceeding 12 years.

Purpose of the Study:

• To provide an updated review of short- and long-term outcomes in heart transplantation.
• To focus on advancements in donor allocation, donor pool expansion, and management of complications.

Main Methods:

• Review of current literature and clinical practices in heart transplantation.
• Analysis of data concerning donor allocation systems and strategies to increase donor availability.
• Examination of outcomes related to primary graft dysfunction, rejection, and long-term sequelae.

Main Results:

• Heart transplantation provides superior survival for end-stage heart failure.
• Ongoing challenges include donor availability, graft dysfunction, and rejection.
• Long-term complications such as cardiac allograft vasculopathy, malignancy, and renal dysfunction require continued monitoring.

Conclusions:

• Heart transplantation remains a life-saving procedure for advanced heart failure.
• Addressing donor organ scarcity and managing post-transplant complications are critical for improving long-term success.
• Continuous research and clinical advancements are essential for optimizing heart transplant outcomes.